Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)

Running, not enrolling · Phase 2 · Has a placebo group

Conditions studied: Overweight, Type 2 Diabetes, Obesity

In brief

The main purpose of this study is to investigate efficacy and safety of three doses of petrelintide versus placebo in participants with overweight or obesity and type 2 diabetes.

Key facts

Study ID
NCT06926842
Run by
Zealand Pharma
People needed
221
Starts
2025-04-22
Expected to finish
2026-08-13
Last updated by the study team
2026-01-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.